Exploring how proteins interact with sugars in the body
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
This study is all about helping scientists learn more about how proteins and sugars in our bodies interact, which is important for understanding diseases like cancer and autoimmune disorders, so that one day, patients like you might benefit from new treatments and insights.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10875546 on NIH RePORTER |
What this research studies
This research focuses on enhancing access to advanced technologies that study protein-glycan interactions, which are crucial for understanding various biological processes and diseases. By providing resources and expertise in glycosciences, the project aims to support researchers in their efforts to investigate how these interactions affect health and disease. Patients may benefit indirectly as this research could lead to new insights into autoimmune diseases, cancers, and other conditions linked to glycosylation. The project utilizes a collaborative approach, engaging a wide range of laboratories and researchers to maximize the impact of its findings.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with autoimmune diseases, cancers, or other conditions influenced by glycosylation.
Not a fit: Patients with conditions unrelated to glycan interactions or those not involved in the research focus may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding and treating diseases related to glycan interactions, potentially improving patient outcomes.
How similar studies have performed: Previous research in glycosciences has shown promise in understanding disease mechanisms, indicating that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Cummings, Richard D — Beth Israel Deaconess Medical Center
- Study coordinator: Cummings, Richard D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.